Seroprevalence of anti-HCV antibodies among blood donors of north India

Indian Journal of Medical Research

Volumn 138, Issue JUL 2013, 2013, Pages 125-128

  Makroo, R N ^a   Walia, Rimpreet Singh ^a   Chowdhry, Mohit ^a   Bhatia, Aakanksha ^a   Hegde, Vikas ^a   Rosamma, N L ^a  

^a INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

Anti HCV; Blood donors; North India; Seroprevalence

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGE; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIA; MALE; MEDICAL RECORD; RETROSPECTIVE STUDY; SEROPREVALENCE;

BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C ANTIBODIES; HUMANS; INDIA; MALE; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 84881043348     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bihl F, Castelli D, Marincola F, Dodd RY, Brander C. Transfusion-transmitted infections. J Transl Med 2007; 5: 25-7.
2. Pears E. Hepatitis C virus infection: risk factors, diagnosis and mangement. Nurs Stand 2010; 25: 15-7.
3. World Health Organization. Hepatitis C. Fact sheet No.164. Revised October 2000. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/, accessed on March 5, 2009.
4. Jou JH, Muir AJ. In the clinic. Hepatitis C. Ann Intern Med 2008; 148: ITC6-1-ITC6-16.
5. Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Viral Hepat 2002; 9: 84-100.
6. Singh B, Verma M, Verma K. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Jpn J Infect Dis 2004; 57: 49-51.
7. Wilkins T, Malcolm JK, Raina D, Schade RR. Hepatitis C: diagnosis and treatment. Am Fam Physician 2010; 81: 1351-7.
8. Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. Jpn J Infect Dis 2007; 60: 389-91.
9. Jain A, Rana SS, Chakravarty P, Gupta R, Murthy NS, Nath MC, et al. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol 2003; 18: 695-7.
10. Sood G, Chauhan A, Sehgal S, Agnihotri S, Dilawari JB. Antibodies to hepatitis C virus in blood donors. Indian J Gastroenterol 1992; 11: 44-5.
11. Makroo RN, Raina V, Kaushik V. Prevalence of hepatitis C virus antibody in healthy blood donors. Indian J Med Res 1999; 110: 123-5.
12. Choudhury N, Ramesh V, Saraswat S, Naik S. Effectiveness of mandatory transmissible diseases screening in Indian blood donors. Indian J Med Res 1995; 101: 229-32.
13. Arora D, Arora B, Khetarpal A. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in southern Haryana. Indian J Pathol Microbiol 2010; 53: 308-9.
14. Panda M, Kar K. HIV, hepatitis B and C infection status of the blood donors in a blood bank of a tertiary health care centre of Orissa. Indian J Public Health 2008; 52: 43-4.
15. Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, eastern India 2004-2005: Exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 2007; 13: 3730-3.
16. Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 2001; 44: 409-12.
17. Sharma RR, Cheema R, Vajpayee M, Rao U, Kumar S, Marwaha N, et al. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. Natl Med J India 2004; 171: 19-21.
18. Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti HCV) in Madurai, south India. Indian J Med Sci 2000; 54: 270-3.
19. Srikrishna A, Sitalakshmi S, Damodar P. How safe are our safe donors? Indian J Pathol Microbiol 1999; 424: 411-6.
20. Gupta N, Kumar V, Kaur A. Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. Indian J Med Sci 2004; 58: 255-7.
21. Manzoor I, Hashmi N, Daud S, Ajmal S, Fatima H, Rasheed Z, et al. Seroprevalence of transfusion transmissible infections (TTIs) in blood donors. Biomedica 2009; 25: 154-8.
22. Gao X, Cui Q, Shi X, Su J, Peng Z Chen X, et al. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis 2011; 11: 88.
23. th, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-9.
24. Goritsas C, Plerou I, Agaliotis S, Spinthaki R, Mimidis K, Velissaris D, et al. HCV infection in the general population of a Greek island: prevalence and risk factors. Hepatogastroenterology 2000; 47: 782-5.
25. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009; 49: 2214-20.
26. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006; 21: 299-305.
27. Saeed AA, Fairclough D, Al-Admawi AM, Bacchus R, Osoba A, Al-Rasheed A, et al. Hepatitis C virus In Saudi Arabia - a preliminary survey. Saudi Med J 1990; 11: 331-2.
28. Sosa-Jurado F, Santos-López G, Guzmán-Flores B, Ruiz-Conde JI, Meléndez-Mena D, Vargas-Maldonado MT, et al. Hepatitis C virus infection in blood donors from the state of Puebla, Mexico. Virol J 2010; 7: 18-23.
29. Ilako FM, McLigeyo SO, Riyat MS, Lule GN, Okoth FA, Kaptich D. The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya. East Afr Med J 1995; 72: 362-4.
30. Thakral B, Marwaha N, Chawla YK, Saluja K, Sharma A, Sharma RR. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res 2006; 124: 431-8.